In Europe, PPD has qualified persons (QPs) who are experienced and trained in the European Union (EU) QP requirements.
Our QPs ensure investigational medicinal products (IMPs) are released smoothly by providing effective communication and transition management with external contractors.
By using QP release with services offered by our clinical supply management team, PPD ensures a direct pathway between the importation of medicinal products into the EU and timely shipment to the clinical trial sites.
QP Release Services
The QPs facilitate the smooth transition through the regulatory process for release. PPD offers a variety of services, including:
- Up-front consultancy to streamline the process
- Advice on EU good manufacturing practices (GMP) compliance, particularly related to investigational medicinal products
- Auditing of third parties (if required)